NCT07604220Recruiting

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Mayo Clinic

Start Date

7/13/2026

Completion Date

7/1/2028

Summary

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria * Adults ≥18 years. * Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis. * Undergoing FDG-PET as part of standard care. * Ability to provide informed consent. Exclusion Criteria • Inability to provide informed consent.

Interventions

OTHER

Exosome Analysis

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cardiac SarcoidosisSarcoidosis of the HeartSarcoidosis With MyocarditisSarcoidosis, Cardiac

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Coordinate outreach and marketing across multiple sites as one effort, plus study-site logistics and tech support.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.